Search

Search Results

• 

  Impact of a nutrition/educational program in a group of type 2 diabetes patients, already involved in a wider "Group Care" plan and not achieving complete target: an observational study

  Anna Comba, Alessandra Ardizzone, Laura Leto, Mauro Feola

  2017-05-18

  Published: May 18, 2017

  1691

  PDF: 940

• Diabetes mellitus in acute exacerbation of chronic obstructive pulmonary disease – the tip of the iceberg

  Devika Tayal, Prerna Jain, Mamta Bhardwaj, Amit Sharma

  2023-11-06

  Published: November 6, 2023

  666

  PDF_early view: 265

• Validation of the Italian version of the questionnaire on nutrition knowledge by Moynihan

  Letizia da Vico, Barbara Biffi, Susanna Agostini, Silvia Brazzo, Maria Luisa Masini, Francesco Fattirolli, Edoardo Mannucci

  2015-12-23

  Published: December 23, 2015

  1145

  PDF: 1094
• 

  Modulation of insulin resistance by renin angiotensin system inhibitors: implications for cardiovascular prevention

  Valeria Valente, Raffaele Izzo, Maria Virginia Manzi, Maria Rosaria De Luca, Emanuele Barbato, Carmine Morisco

  2021-03-11

  Published: March 11, 2021

  1703

  PDF: 703

• Endothelial dysfunction in type 2 diabetic patients with normal coronary arteries. A peripheral arterial tonometry study

  Donatella Ruggiero, Gianluigi Savarese, Roberto Formisano, Ada Bologna, Giacomo Mattiello, Elisabetta Pirozzi, Francesco Gambardella, Francesco Lo Iudice, Laura Petraglia, Alice Vitagliano, Laura Casaretti, Giuseppe Luca Della Ratta, Susanna Mosca, Pasquale Perrone Filardi

  2015-12-03

  Published: December 3, 2015

  1142

  PDF: 536
• 

  Secondary prevention advices after cardiovascular index event: From drug prescription to risk factors control in real world practice

  Pompilio Faggiano, Francesco Fattirolli, Anna Frisinghelli, Lucrezia Piccioli, Nicolò Dasseni, Maria Vittoria Silverii, Laura Albricci, Giuseppe D'Ambrosio, Rosaria Garrì, Luigi Esposito, Francesco Giallauria

  2019-05-20

  Published: May 20, 2019

  2430

  PDF: 1568
• 

  High thrombotic risk increases adverse clinical events up to 5 years after acute myocardial infarction. A nationwide retrospective cohort study

  Gian Francesco Mureddu, Cesare Greco, Stefano Rosato, Paola D'Errigo, Leonardo De Luca, Gabriella Badoni, Pompilio Faggiano, Fulvia Seccareccia

  2019-11-21

  Published: November 21, 2019

  1026

  PDF: 611

  Supplementary: 179
• 

  Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series

  Brandon Iturbe Esquivel, José Meneses Calderón, Luis Edgar Concepción Carrillo, Hugo Mendieta Zeron

  2022-06-08

  Published: June 8, 2022

  1648

  PDF: 489
• 

  Pulmonary adverse events due to immune checkpoint inhibitors: A literature review

  Vasiliki Epameinondas Georgakopoulou, Nikolaos Garmpis, Dimitrios Mermigkis, Christos Damaskos, Serafeim Chlapoutakis, Konstantinos Mantzouranis, Aikaterini Gkoufa, Chrysovalantis Papageorgiou, Anna Garmpi, Sotiria Makrodimitri, Evangelos Diamantis, Pagona Sklapani, Nikolaos Trakas, Xanthi Tsiafaki

  2021-10-11

  Published: October 11, 2021

  1799

  PDF: 880